1、raising standards worldwideNO COPYING WITHOUT BSI PERMISSION EXCEPT AS PERMITTED BY COPYRIGHT LAWBSI Standards PublicationBS EN ISO 10993-12:2012Biological evaluation of medical devicesPart 12: Sample preparation and reference materialsBS EN ISO 10993-12:2012 BRITISH STANDARDNational forewordThis Br
2、itish Standard is the UK implementation of EN ISO 10993-12:2012. It supersedes BS EN ISO 10993-12:2009,which is withdrawn.The UK participation in its preparation was entrusted to Technical Committee CH/194, Biological evaluation of medical devices.A list of organizations represented on this committe
3、e can be obtained on request to its secretary.This publication does not purport to include all the necessary provisions of a contract. Users are responsible for its correct application. The British Standards Institution 2012. Published by BSI Standards Limited 2012.ISBN 978 0 580 66252 2 ICS 11.100.
4、20 Compliance with a British Standard cannot confer immunity from legal obligations.This British Standard was published under the authority of the Standards Policy and Strategy Committee on 31 October 2012.Amendments issued since publicationDate T e x t a f f e c t e dEUROPEAN STANDARD NORME EUROPEN
5、NE EUROPISCHE NORM EN ISO 10993-12 July 2012 ICS 11.100.20 Supersedes EN ISO 10993-12:2009English Version Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2012) valuation biologique des dispositifs mdicaux - Partie 12: Prparation des chanti
6、llons et matriaux de rfrence (ISO 10993-12:2012) Biologische Beurteilung von Medizinprodukten - Teil 12: Probenvorbereitung und Referenzmaterialien (ISO 10993-12:2012) This European Standard was approved by CEN on 30 June 2012. CEN members are bound to comply with the CEN/CENELEC Internal Regulation
7、s which stipulate the conditions for giving this European Standard the status of a national standard without any alteration. Up-to-date lists and bibliographical references concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN member. Th
8、is European Standard exists in three official versions (English, French, German). A version in any other language made by translation under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management Centre has the same status as the official versions. CEN mem
9、bers are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portu
10、gal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom. EUROPEAN COMMITTEE FOR STANDARDIZATION COMIT EUROPEN DE NORMALISATION EUROPISCHES KOMITEE FR NORMUNG Management Centre: Avenue Marnix 17, B-1000 Brussels 2012 CEN All rights of exploitation in any form and by an
11、y means reserved worldwide for CEN national Members. Ref. No. EN ISO 10993-12:2012: EBS EN ISO 10993-12:2012 EN ISO 10993-12:2012 (E) 3 Foreword This document (EN ISO 10993-12:2012) has been prepared by Technical Committee ISO/TC 194 “Biological evaluation of medical devices“ in collaboration with T
12、echnical Committee CEN/TC 206 “Biological evaluation of medical devices” the secretariat of which is held by NEN. This European Standard shall be given the status of a national standard, either by publication of an identical text or by endorsement, at the latest by January 2013, and conflicting nati
13、onal standards shall be withdrawn at the latest by January 2013. Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. CEN and/or CENELEC shall not be held responsible for identifying any or all such patent rights. This document superse
14、des EN ISO 10993-12:2009. This document has been prepared under a mandate given to CEN by the European Commission and the European Free Trade Association, and supports essential requirements of EU Directives. For relationship with EU Directives, see informative Annex ZA and ZB, which are an integral
15、 parts of this document. According to the CEN/CENELEC Internal Regulations, the national standards organizations of the following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, Former Yugoslav Republic
16、of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and the United Kingdom. Endorsement notice The text of ISO 10993-12:2012 has been approved by
17、CEN as a EN ISO 10993-12:2012 without any modification. BS EN ISO 10993-12:2012EN ISO 10993-12:2012 (E) 4 Annex ZA (informative) Relationship between this European Standard and the Essential Requirements of EU Directive 93/42/EEC on medical devices This European Standard has been prepared under a ma
18、ndate given to CEN by the European Commission and the European Free Trade Association to provide a means of conforming to Essential Requirements of the New Approach Directive 93/42/EEC on medical devices. Once this standard is cited in the Official Journal of the European Union under that Directive
19、and has been implemented as a national standard in at least one Member State, compliance with the clauses of this standard given in Table ZA.1 confers, within the limits of the scope of this standard, a presumption of conformity with the corresponding Essential Requirements of that Directive and ass
20、ociated EFTA regulations. Table ZA.1 Correspondence between this European Standard and Directive 93/42/EEC on medical devices Clauses of this European Standard Essential Requirements (ERs) of Directive 93/42/EEC Qualifying remarks/Notes 4, 5, 6, 7, 8, 9, 10, 11 7.2 first sentence only This standard
21、provides a means of preparing samples to assess conformity with this part of this ER in conjunction with other relevant parts of EN ISO 10993 for the design and manufacture of medical devices. Packaging is not covered. 4, 5, 6, 7, 8, 9, 10 , 11 7.5 first paragraph only This standard provides a means
22、 of preparing samples of medical devices to assess conformity with this part of this ER in conjunction with other relevant parts of EN ISO 10993. WARNING Other requirements and other EU Directives may be applicable to the product(s) falling within the scope of this standard. BS EN ISO 10993-12:2012
23、EN ISO 10993-12:2012 (E) 5 Annex ZB (informative) Relationship between this European Standard and the Essential Requirements of EU Directive 90/385/EEC on active implantable medical devices This European Standard has been prepared under a mandate given to CEN by the European Commission and the Europ
24、ean Free Trade Association to provide a means of conforming to Essential Requirements of the New Approach Directive 90/385/EEC on active implantable medical devices. Once this standard is cited in the Official Journal of the European Union under that Directive and has been implemented as a national
25、standard in at least one Member State, compliance with the clauses of this standard given in Table ZB.1 confers, within the limits of the scope of this standard, a presumption of conformity with the corresponding Essential Requirements of that Directive and associated EFTA regulations. Table ZB.1 Co
26、rrespondence between this European Standard and Directive 90/385/EEC on active implantable medical devices Clauses of this European Standard Essential Requirements (ERs) of Directive 90/385/EEC Qualifying remarks/Notes 4, 5, 6, 7, 8, 9, 10, 11 9 (first and second indents only) This standard provides
27、 a means of preparing samples of medical devices to assess conformity with these parts of this ER in conjunction with other relevant parts of EN ISO 10993. WARNING Other requirements and other EU Directives may be applicable to the product(s) falling within the scope of this standard. BS EN ISO 1099
28、3-12:2012ISO 10993-12:2012(E) ISO 2012 All rights reserved iiiContents PageForeword ivIntroduction v1 Scope 12 Normative references . 13 Terms and definitions . 14 General requirements . 35 Reference materials (RMs) 45.1 General . 45.2 Certification of RMs for biological safety testing . 46 Use of R
29、Ms as experimental controls 47 Test sample selection . 58 Test sample and RM preparation 59 Selection of representative portions from a device . 510 Preparation of extracts of samples 610.1 General . 610.2 Containers for extraction 610.3 Extraction conditions and methods . 610.4 Extraction condition
30、s for hazard identification and risk estimation in the exaggerated-use condition (points to consider in relation to Annex D) . 911 Records 9Annex A (informative) Experimental controls .10Annex B (informative) General principles on, and practices of, test sample preparation and sample selection 12Ann
31、ex C (informative) Principles of test sample extraction14Annex D (informative) Exhaustive extraction of polymeric materials for biological evaluation .17Bibliography .19BS EN ISO 10993-12:2012ISO 10993-12:2012(E)ForewordISO (the International Organization for Standardization) is a worldwide federati
32、on of national standards bodies (ISO member bodies). The work of preparing International Standards is normally carried out through ISO technical committees. Each member body interested in a subject for which a technical committee has been established has the right to be represented on that committee
33、. International organizations, governmental and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.International Standards are drafted in accordance wi
34、th the rules given in the ISO/IEC Directives, Part 2.The main task of technical committees is to prepare International Standards. Draft International Standards adopted by the technical committees are circulated to the member bodies for voting. Publication as an International Standard requires approv
35、al by at least 75 % of the member bodies casting a vote.Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. ISO shall not be held responsible for identifying any or all such patent rights.ISO 10993-12 was prepared by Technical Committ
36、ee ISO/TC 194, Biological evaluation of medical devices.This fourth edition cancels and replaces the third edition (ISO 10993-12:2007), which has been technically revised.ISO 10993 consists of the following parts, under the general title Biological evaluation of medical devices: Part 1: Evaluation a
37、nd testing within a risk management process Part 2: Animal welfare requirements Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity Part 4: Selection of tests for interactions with blood Part 5: Tests for in vitro cytotoxicity Part 6: Tests for local effects after implantation
38、Part 7: Ethylene oxide sterilization residuals Part 9: Framework for identification and quantification of potential degradation products Part 10: Tests for irritation and skin sensitization Part 11: Tests for systemic toxicity Part 12: Sample preparation and reference materials Part 13: Identificati
39、on and quantification of degradation products from polymeric medical devices Part 14: Identification and quantification of degradation products from ceramics Part 15: Identification and quantification of degradation products from metals and alloys Part 16: Toxicokinetic study design for degradation
40、products and leachables Part 17: Establishment of allowable limits for leachable substances Part 18: Chemical characterization of materials Part 19: Physico-chemical, morphological and topographical characterization of materials Technical Specification Part 20: Principles and methods for immunotoxic
41、ology testing of medical devices Technical Specificationiv ISO 2012 All rights reservedBS EN ISO 10993-12:2012ISO 10993-12:2012(E)IntroductionThis part of ISO 10993 specifies methods of sample preparation and provides requirements and guidance for the selection of reference materials for the biologi
42、cal evaluation of medical devices.It is important that sample preparation methods be appropriate for both the biological evaluation methods and the materials being evaluated. Each biological test method requires the selection of materials, extraction solvents and conditions.This part of ISO 10993 is
43、 based on existing national and international specifications, regulations and standards wherever possible. It is periodically reviewed and revised. ISO 2012 All rights reserved vBS EN ISO 10993-12:2012BS EN ISO 10993-12:20121 ScopeThis part of ISO 10993 specifies requirements and gives guidance on t
44、he procedures to be followed in the preparation of samples and the selection of reference materials for medical device testing in biological systems in accordance with one or more parts of ISO 10993. Specifically, this part of ISO 10993 addresses the following: test sample selection; selection of re
45、presentative portions from a device; test sample preparation; experimental controls; selection of, and requirements, for reference materials; preparation of extracts.This part of ISO 10993 is not applicable to live cells, but can be relevant to the material or device components of combination produc
46、ts containing live cells.2 Normative referencesThe following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies.ISO
47、 10993 (all parts), Biological evaluation of medical devicesISO 14971, Medical devices Application of risk management to medical devices3 Terms and definitionsFor the purposes of this document, the following terms and definitions apply.3.1accelerated extractionextraction that provides a measure of t
48、he leachable or extractable materials of the device or material, using conditions that shorten the time for leaching of the substances into the extraction vehicle but do not result in a chemical change of the substances being extractedEXAMPLE Elevated temperature, agitation, changing of the extracti
49、on vehicle.3.2blankextraction vehicle not containing the test material, which is retained in a vessel identical to that holding the test sample and subjected to conditions identical to the ones the test sample is subjected to during its extractionNOTE The purpose of the blank is to evaluate possible confounding effects due to the extraction vessel, extraction vehicle and extraction process.INTERNATIONAL STANDARD ISO 10993-12:2012(E) ISO 2012 All rights reserved 1BS EN ISO 10993-12:2012ISO 10993-12:2012(E)3.3CRMcertified re
